Cargando…

Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy

β-alanine is an amino acid that, when combined with histidine, forms the dipeptide carnosine within skeletal muscle. Carnosine and β-alanine each have multiple purposes within the human body; this review focuses on their roles as ergogenic aids to exercise performance and suggests how to best quanti...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, John, Charles, Jessica, Unruh, Kayla, Giebel, Rachel, Learmonth, Lexis, Potter, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407982/
https://www.ncbi.nlm.nih.gov/pubmed/22852051
http://dx.doi.org/10.3390/nu4070585
_version_ 1782239415659134976
author Caruso, John
Charles, Jessica
Unruh, Kayla
Giebel, Rachel
Learmonth, Lexis
Potter, William
author_facet Caruso, John
Charles, Jessica
Unruh, Kayla
Giebel, Rachel
Learmonth, Lexis
Potter, William
author_sort Caruso, John
collection PubMed
description β-alanine is an amino acid that, when combined with histidine, forms the dipeptide carnosine within skeletal muscle. Carnosine and β-alanine each have multiple purposes within the human body; this review focuses on their roles as ergogenic aids to exercise performance and suggests how to best quantify the former’s merits as a buffer. Carnosine normally makes a small contribution to a cell’s total buffer capacity; yet β-alanine supplementation raises intracellular carnosine concentrations that in turn improve a muscle’s ability to buffer protons. Numerous studies assessed the impact of oral β-alanine intake on muscle carnosine levels and exercise performance. β-alanine may best act as an ergogenic aid when metabolic acidosis is the primary factor for compromised exercise performance. Blood lactate kinetics, whereby the concentration of the metabolite is measured as it enters and leaves the vasculature over time, affords the best opportunity to assess the merits of β-alanine supplementation’s ergogenic effect. Optimal β-alanine dosages have not been determined for persons of different ages, genders and nutritional/health conditions. Doses as high as 6.4 g day(−1), for ten weeks have been administered to healthy subjects. Paraesthesia is to date the only side effect from oral β-alanine ingestion. The severity and duration of paraesthesia episodes are dose-dependent. It may be unwise for persons with a history of paraesthesia to ingest β-alanine. As for any supplement, caution should be exercised with β-alanine supplementation.
format Online
Article
Text
id pubmed-3407982
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-34079822012-07-31 Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy Caruso, John Charles, Jessica Unruh, Kayla Giebel, Rachel Learmonth, Lexis Potter, William Nutrients Review β-alanine is an amino acid that, when combined with histidine, forms the dipeptide carnosine within skeletal muscle. Carnosine and β-alanine each have multiple purposes within the human body; this review focuses on their roles as ergogenic aids to exercise performance and suggests how to best quantify the former’s merits as a buffer. Carnosine normally makes a small contribution to a cell’s total buffer capacity; yet β-alanine supplementation raises intracellular carnosine concentrations that in turn improve a muscle’s ability to buffer protons. Numerous studies assessed the impact of oral β-alanine intake on muscle carnosine levels and exercise performance. β-alanine may best act as an ergogenic aid when metabolic acidosis is the primary factor for compromised exercise performance. Blood lactate kinetics, whereby the concentration of the metabolite is measured as it enters and leaves the vasculature over time, affords the best opportunity to assess the merits of β-alanine supplementation’s ergogenic effect. Optimal β-alanine dosages have not been determined for persons of different ages, genders and nutritional/health conditions. Doses as high as 6.4 g day(−1), for ten weeks have been administered to healthy subjects. Paraesthesia is to date the only side effect from oral β-alanine ingestion. The severity and duration of paraesthesia episodes are dose-dependent. It may be unwise for persons with a history of paraesthesia to ingest β-alanine. As for any supplement, caution should be exercised with β-alanine supplementation. MDPI 2012-06-26 /pmc/articles/PMC3407982/ /pubmed/22852051 http://dx.doi.org/10.3390/nu4070585 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Caruso, John
Charles, Jessica
Unruh, Kayla
Giebel, Rachel
Learmonth, Lexis
Potter, William
Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
title Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
title_full Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
title_fullStr Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
title_full_unstemmed Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
title_short Ergogenic Effects of β-Alanine and Carnosine: Proposed Future Research to Quantify Their Efficacy
title_sort ergogenic effects of β-alanine and carnosine: proposed future research to quantify their efficacy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407982/
https://www.ncbi.nlm.nih.gov/pubmed/22852051
http://dx.doi.org/10.3390/nu4070585
work_keys_str_mv AT carusojohn ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy
AT charlesjessica ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy
AT unruhkayla ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy
AT giebelrachel ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy
AT learmonthlexis ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy
AT potterwilliam ergogeniceffectsofbalanineandcarnosineproposedfutureresearchtoquantifytheirefficacy